Search research articles
Contact Us
Filters
Showing results (31-40 of 115) with videos related to
Page
of 12
Sort By:
British Journal of Pharmacology
|
March 8, 2018
Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)
Marilena Crescente, Laura Menke, Melissa V Chan, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 29, 2012
Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers
Tommy Andersson, Dennis Morrison, Péter Nagy, et al.
Heart (British Cardiac Society)
|
October 20, 2010
Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?
Timothy D Warner, Paul C J Armstrong, Nicholas P Curzen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 22, 2009
PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report
Ferhana Y Ali, Matthew G Hall, Béatrice Desvergne, et al.
Molecular Pharmacology
|
October 23, 2002
Cyclooxygenase-2 acts as an endogenous brake on endothelin-1 release by human pulmonary artery smooth muscle cells: implications for pulmonary hypertension
Stephen J Wort, Mandy Woods, Timothy D Warner, et al.
Shock (Augusta, Ga.)
|
June 15, 2007
Identification and characterization of a dysfunctional cardiac myocyte phenotype: role of bacteria, Toll-like receptors, and endothelin
Trupti A Patel, Elizabeth Belcher, Timothy D Warner, et al.
Life Sciences
|
August 15, 2002
Endothelin in human inflammatory bowel disease: comparison to rat trinitrobenzenesulphonic acid-induced colitis
Sara A McCartney, Anne B Ballinger, Ivana Vojnovic, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 19, 2004
Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues
Timothy D Warner, Ivana Vojnovic, Francesco Giuliano, et al.
Platelets
|
August 3, 2011
Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing
Melissa V Chan, Paul C J Armstrong, Francesco Papalia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 5, 2006
Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events
Jane A Mitchell, Ruth Lucas, Ivana Vojnovic, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 115) with videos related to
Sort By:
Page
of 12
British Journal of Pharmacology
|
March 8, 2018
Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)
Marilena Crescente, Laura Menke, Melissa V Chan, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 29, 2012
Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers
Tommy Andersson, Dennis Morrison, Péter Nagy, et al.
Heart (British Cardiac Society)
|
October 20, 2010
Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?
Timothy D Warner, Paul C J Armstrong, Nicholas P Curzen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 22, 2009
PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report
Ferhana Y Ali, Matthew G Hall, Béatrice Desvergne, et al.
Molecular Pharmacology
|
October 23, 2002
Cyclooxygenase-2 acts as an endogenous brake on endothelin-1 release by human pulmonary artery smooth muscle cells: implications for pulmonary hypertension
Stephen J Wort, Mandy Woods, Timothy D Warner, et al.
Shock (Augusta, Ga.)
|
June 15, 2007
Identification and characterization of a dysfunctional cardiac myocyte phenotype: role of bacteria, Toll-like receptors, and endothelin
Trupti A Patel, Elizabeth Belcher, Timothy D Warner, et al.
Life Sciences
|
August 15, 2002
Endothelin in human inflammatory bowel disease: comparison to rat trinitrobenzenesulphonic acid-induced colitis
Sara A McCartney, Anne B Ballinger, Ivana Vojnovic, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 19, 2004
Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues
Timothy D Warner, Ivana Vojnovic, Francesco Giuliano, et al.
Platelets
|
August 3, 2011
Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing
Melissa V Chan, Paul C J Armstrong, Francesco Papalia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 5, 2006
Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events
Jane A Mitchell, Ruth Lucas, Ivana Vojnovic, et al.
Page
of 12